Ling-Yan Su | Molecular Neuroscience | Best Researcher Award

Posted on 30/06/2025 by Neuroscientists

Dr. Ling-Yan Su | Molecular Neuroscience | Best Researcher Award

Dr. Ling-Yan Su, Yunnan Agricultural University, China.

Professor Ling-Yan Su is a leading figure in the field of food science and plant physiology, currently serving at the College of Food Science and Technology, Yunnan Agricultural University. With a solid academic foundation from Yunnan University and the Chinese Academy of Sciences, she has built a dynamic career that bridges molecular biology and applied agricultural research. Her pioneering work on melatonin-based pre-harvest treatments has significantly advanced our understanding of natural preservation techniques, especially in prolonging the post-harvest life and quality of fruits like Myrica rubra. Her research focuses on enhancing antioxidant systems, inhibiting spoilage, and activating plant defense pathways through sustainable, low-toxicity treatments.

Profile

Google Scholar

🎓 Early Academic Pursuits

Ling-Yan Su’s journey in the biological sciences began with a Bachelor of Science degree from the School of Life Science at Yunnan University (2007–2011). Demonstrating academic curiosity and determination early on, she expanded her horizons through a year-long visiting student program (2010–2011) at the prestigious Kunming Institute of Zoology, affiliated with the Chinese Academy of Sciences. This experience laid the foundation for her doctoral research, which she pursued at the same institute from 2011 to 2017, where she rigorously explored complex biological systems, further solidifying her passion for food science and plant physiology.

🧪 Professional Endeavors in Science

Professor Su’s professional career has been marked by consistent growth across esteemed academic institutions. Following her Ph.D., she joined the Kunming Institute of Zoology as a research assistant, rapidly advancing to the role of associate professor. In 2022, she transitioned to the College of Food Science and Technology at Yunnan Agricultural University, initially as an associate professor before her promotion to full professor within the same year. Her academic trajectory reflects a blend of deep research engagement and an evolving role in shaping food science education and innovation in China.

🌿 Contributions and Research Focus

Professor Su’s groundbreaking work lies at the intersection of plant physiology, post-harvest fruit biology, and food preservation technology. She has made significant contributions to understanding how melatonin, a naturally occurring compound, can be leveraged to extend the post-harvest shelf life of Myrica rubra (Chinese bayberry). Her studies demonstrate that melatonin pre-harvest treatments reduce oxidative stress markers, inhibit microbial decay, and activate the phenylpropanoid pathway, resulting in elevated antioxidant activity. This line of research not only reveals novel mechanisms of fruit preservation but also opens sustainable avenues in post-harvest biology and food safety.

🏅 Accolades and Recognition

While formal awards are not listed, Professor Su’s rapid academic promotions and appointments at prestigious research institutes such as the Chinese Academy of Sciences and Yunnan Agricultural University underscore her recognition within the scientific community. Her work is contributing to a growing body of literature on sustainable food science innovations, earning her esteem among peers and collaborators in the agricultural biotechnology field.

🌱 Impact and Influence

Professor Su’s innovative application of melatonin in fruit preservation has substantial implications for food technology and agricultural practices. Her research directly addresses global concerns such as food spoilage, post-harvest losses, and chemical-free preservation methods. By enhancing natural antioxidant defenses and inhibiting spoilage at a molecular level, her work supports both farmers and consumers in accessing healthier and longer-lasting produce, especially within the context of environmentally conscious food systems.

🔬 Legacy in Food Science

The legacy Professor Su is building centers around translating scientific inquiry into practical solutions for real-world agricultural challenges. Her research is charting a course for future studies in the bio-preservation of fruits and vegetables using natural treatments. As she continues to mentor students and collaborate across disciplines, her influence is extending into the next generation of food scientists and researchers focused on plant biochemistry, post-harvest technology, and sustainable agricultural innovation.

🚀 Future Contributions and Vision

Looking ahead, Professor Ling-Yan Su is poised to further explore how endogenous compounds like melatonin can be applied across various fruits and food crops. Her vision includes broadening the scope of natural food preservation strategies and delving deeper into molecular pathways that regulate plant defense responses. As a respected academic and scientist, her future contributions are expected to shape healthier food systems and deepen scientific understanding of plant–microbe–compound interactions.

Publication

Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)
Authors: DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, …
Year: 2021

Activation of PPARA-mediated autophagy reduces Alzheimer disease-like pathology and cognitive decline in a murine model
Authors: R Luo, LY Su, G Li, J Yang, Q Liu, LX Yang, DF Zhang, H Zhou, M Xu, …
Year: 2020

Melatonin attenuates MPTP-induced neurotoxicity via preventing CDK5-mediated autophagy and SNCA/α-synuclein aggregation
Authors: LY Su, H Li, L Lv, YM Feng, GD Li, R Luo, HJ Zhou, XG Lei, L Ma, JL Li, …
Year: 2015

Decreased mitochondrial DNA copy number in the hippocampus and peripheral blood during opiate addiction is mediated by autophagy and can be salvaged by melatonin
Authors: YM Feng, YF Jia, LY Su, D Wang, L Lv, L Xu, YG Yao
Year: 2013

Association of the LRRK2 genetic polymorphisms with leprosy in Han Chinese from Southwest China
Authors: D Wang, L Xu, L Lv, LY Su, Y Fan, DF Zhang, R Bi, D Yu, W Zhang, XA Li, …
Year: 2015

Atg5- and Atg7-dependent autophagy in dopaminergic neurons regulates cellular and behavioral responses to morphine
Authors: LY Su, R Luo, Q Liu, JR Su, LX Yang, YQ Ding, L Xu, YG Yao
Year: 2017

Positive selection rather than relaxation of functional constraint drives the evolution of vision during chicken domestication
Authors: MS Wang, R Zhang, LY Su, Y Li, MS Peng, HQ Liu, L Zeng, DM Irwin, …
Year: 2016

Melatonin alleviates morphine analgesic tolerance in mice by decreasing NLRP3 inflammasome activation
Authors: Q Liu, LY Su, C Sun, L Jiao, Y Miao, M Xu, R Luo, X Zuo, R Zhou, P Zheng, …
Year: 2020

Out of Southern East Asia of the brown rat revealed by large-scale genome sequencing
Authors: L Zeng, C Ming, Y Li, LY Su, YH Su, NO Otecko, A Dalecky, S Donnellan, …
Year: 2018

Moringa oleifera Lam. leaves as new raw food material: A review of its nutritional composition, functional properties, and comprehensive application
Authors: M Yang, L Tao, XR Kang, ZL Wang, LY Su, LF Li, F Gu, CC Zhao, J Sheng, …
Year: 2023

✅ Conclusion

Professor Su’s academic journey and research contributions exemplify scientific excellence rooted in sustainability and innovation. Her work not only provides practical solutions to post-harvest challenges but also contributes to broader efforts in reducing food waste and promoting natural preservation methods. As she continues to mentor young researchers and expand her studies, Professor Su is well-positioned to leave a lasting impact on food science and agricultural biotechnology. Her career reflects a thoughtful integration of research, application, and forward-looking vision in the quest for healthier and more resilient food systems.

Georgia Kaiafa | Clinical Neuroscience | Best Researcher Award

Posted on 20/06/2025 by Neuroscientists

Assoc. Prof. Dr. Georgia Kaiafa | Clinical Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Georgia Kaiafa, Medical School, Aristotle University of Thessaloniki, Greece.

Dr. Georgia Kaiafa is a distinguished hematologist and academician whose career spans clinical excellence, impactful research, and dedicated teaching. A graduate of Aristotle University of Thessaloniki, she earned her MBBS in 1987, Board Certification in Hematology in 1996, and completed her Doctorate in 2005. Her academic roles have progressed from Lecturer to Associate Professor of Hematology and Thromboembolic Diseases, with a longstanding association at AHEPA University Hospital.

Profile

Scopus

🎓 Early Academic Pursuits

Georgia Kaiafa began her academic journey in medicine at the prestigious Aristotle University of Thessaloniki, enrolling in the Medical School in 1980. Her foundational training was marked by determination and intellectual rigor, culminating in the completion of her MBBS in 1987. A steadfast commitment to advanced education led her to earn her Board Certification in Haematology by 1996, and later, she successfully defended her Doctorate thesis in 2005. These formative years reflect her deep-rooted passion for understanding hematological science and its clinical applications.

🧬 Professional Endeavors in Hematology

Her professional journey has been nothing short of inspiring, anchored in both clinical excellence and academic growth. Georgia Kaiafa has served in several academic ranks, beginning as a Lecturer in Hematology from 2007 to 2015, advancing to Assistant Professor until 2021, and currently holding the esteemed position of Associate Professor of Hematology and Thromboembolic Diseases. She is affiliated with AHEPA University Hospital’s Hematology Department, a major center of excellence in Greece. Her expertise was further enriched by her tenure as a Visiting Research Associate at King’s College Hospital in London in 2012, where she gained valuable international exposure. Since 2005, she has also played a leadership role as a Coordinator in the Northern Greece Office of the Health Sector, bridging academic medicine and healthcare policy.

🩸 Contributions and Research Focus

Georgia Kaiafa has devoted her scholarly efforts to advancing the understanding of thrombosis, thromboembolic disorders, and hematological malignancies. With her contributions to over 95 peer-reviewed international journal publications and participation as a Principal Investigator in 26 research trials, she has carved out a niche in evidence-based hematological research. Her investigations have deeply influenced protocols and practices in vascular pharmacology, hematologic diagnostics, and the clinical management of thrombotic conditions. She is also a prominent educator, mentoring Ph.D. candidates and contributing to postgraduate programs for both Greek and international students.

🏆 Accolades and Recognition

Her scientific contributions have not gone unnoticed. Georgia Kaiafa has received significant national acclaim, including the 1st Prize Award for Best Paper at the Pan-Hellenic Haematology Conference in 2008 and again at the 1st Conference of Internal Medicine of Northern Greece in 2015. These accolades affirm her research excellence and clinical insight. Her expertise has earned her memberships in elite national and international medical societies, including the Hellenic Stroke Organization and the European Stroke Organization, as well as a respected position in the Excellence of Thrombosis initiative.

🌍 Impact and Influence

Beyond academia and clinical service, Kaiafa has exerted influence on multiple scientific fronts. As a reviewer for prominent journals such as Thrombosis Research, Anemia, Case Reports in Hematology, and the Indian Heart Journal, she ensures high scientific standards in hematologic research worldwide. Her editorial work for both international and Greek journals demonstrates her authority in the field and her dedication to the progression of scientific communication. Her wide-ranging collaborations and committee leadership roles have significantly influenced health education and medical research in Greece and abroad.

📚 Scholarly Engagement and Mentorship

Georgia Kaiafa is not only a prolific researcher but also a passionate mentor and academic contributor. With 23 chapters in medical books, over 130 abstracts in Greek conference proceedings, and nearly 100 abstracts presented in international forums, her voice resonates across the global hematology community. She has mentored and supervised numerous doctoral students, serving on committees for 12 Ph.D. projects and directly supervising five, cultivating the next generation of scientific minds. She has also chaired 22 congress sessions and delivered more than 100 invited talks, emphasizing her respected role as both speaker and thought leader.

🔬 Legacy and Future Contributions

As a seasoned academic and clinical researcher, Georgia Kaiafa continues to shape the future of hematology in Greece and beyond. Her legacy lies in her dual commitment to clinical care and scientific discovery, especially in the realm of thromboembolic diseases and hematologic innovations. Her ongoing involvement in research protocols, editorial responsibilities, and student mentorship assures that her influence will persist. With a solid foundation and a career marked by excellence, her future contributions are likely to further impact hematological sciences and translational medicine globally.

publication

Title: Monocyte Chemoattractant Protein-1 as a Biomarker in Acute Ischemic Stroke: A Prospective Pilot Study
Author(s): [Not specified]
Year: 2025

Title: Prospective Study of ADAMTS13 and von Willebrand Factor’s Role in the Prediction of Outcomes in Acute Ischemic Stroke
Author(s): [Not specified]
Year: 2025

Title: Antiphospholipid Syndrome: A Comprehensive Clinical Review
Author(s): [Not specified]
Year: [Not specified]

Title: The Seasonal Distribution of Immune Thrombotic Thrombocytopenic Purpura is Influenced by Geography: Epidemiologic Findings from a Multi-Center Analysis of 719 Disease Episodes
Author(s): [Not specified]
Year: 2024

Title: Current Trends in Stroke Biomarkers: The Prognostic Role of S100 Calcium-Binding Protein B and Glial Fibrillary Acidic Protein
Author(s): [Not specified]
Year: [Not specified]

Title: Outpatient Management After Hospitalisation for Acute Decompensation of Cirrhosis: A Practical Guide
Author(s): [Not specified]
Year: 2024

Title: Which Is the Best Way to Treat Massive Hemoptysis? A Systematic Review and Meta-Analysis of Observational Studies
Author(s): [Not specified]
Year: [Not specified]

Title: Post-COVID-19 and Irritable Bowel Syndrome: A Literature Review
Author(s): [Not specified]
Year: [Not specified]

Title: Thyroid Disease and Systemic Lupus Erythematosus
Author(s): [Not specified]
Year: 2023

🏁 Conclusion

Dr. Georgia Kaiafa embodies the values of academic integrity, scientific advancement, and clinical leadership. Her commitment to both national healthcare development and international scientific collaboration sets her apart. With a strong foundation in research, education, and public health, she not only meets but exceeds the criteria for recognition through the Best Researcher Award. Her body of work stands as a testament to sustained excellence and future promise in hematology and related disciplines.

Joice Margareth de Almeida Rodolpho | Molecular Neuroscience | Best Researcher Award

Posted on 14/06/2025 by Neuroscientists

Mrs. Joice Margareth de Almeida Rodolpho | Molecular Neuroscience | Best Researcher Award

Mrs. Joice Margareth de Almeida Rodolpho, Universidade Federal de São Carlos, Brazil.

Joice Margareth de Almeida Rodolpho is a dedicated Brazilian researcher with a strong foundation in biotechnology, parasitology, immunology, and molecular biology. She earned her Master’s and Ph.D. from the Federal University of São Carlos (UFSCar), where she explored the role of eosinophils as antigen-presenting cells in parasitic infections like Toxocara canis and Schistosoma mansoni. Her work is recognized for integrating experimental immunology with therapeutic innovations, such as the evaluation of natural plant extracts and nanomaterials for infection control. She further specialized in Flow Cytometry and Oncohematology, enhancing her analytical capabilities. With multiple awards and citations, her impactful contributions continue to strengthen Brazil’s standing in parasitological and immunological research.

Profile

Orcid

🎓 Early Academic Pursuits

Joice Margareth de Almeida Rodolpho began her academic journey in Brazil, developing a strong foundation in the life sciences. Her early interest in molecular biology and parasitology led her to pursue advanced studies at the esteemed Universidade Federal de São Carlos (UFSCar). She earned her Master’s degree in Biotechnology between 2009 and 2012, conducting significant research on Toxocara canis, particularly on the phenotypic characterization of eosinophils as antigen-presenting cells. This early work not only revealed her meticulous scientific inquiry but also laid the groundwork for her deeper exploration into immunology.

🧬 Professional Endeavors in Molecular and Evolutionary Genetics

Driven by a passion for understanding immune responses, Joice pursued a Ph.D. in Evolutionary Genetics and Molecular Biology at UFSCar from 2013 to 2017. Her doctoral research focused on the role of eosinophils as antigen-presenting cells both in vitro and ex vivo, offering vital insights into host-parasite interactions and immune regulation. Her work during this period was supported by a prestigious FAPESP scholarship, demonstrating her academic excellence and the relevance of her contributions. Under the mentorship of Professor Fernanda de Freitas Anibal, Joice refined her skills in experimental immunology and cellular biology.

🧪 Contributions and Research Focus in Parasitology and Immunopathology

Joice Rodolpho’s primary research interests lie at the intersection of parasitology, cellular immunology, and experimental pathology. Her studies explore how parasitic infections, such as those caused by Schistosoma mansoni and Toxocara canis, affect immune cell function, especially eosinophils. She has also contributed to investigations into natural plant extracts, like Mentha piperita L., assessing their therapeutic potential in modulating parasitic infections. Moreover, she extended her expertise to the field of nanomaterials, evaluating the cytotoxicity and cell death mechanisms induced by compounds like Ag₂WO₄, thus bridging classical parasitology with emerging biomedical technologies.

🏅 Accolades and Recognition in Scientific Circles

Throughout her career, Joice has received several recognitions that reflect the impact and originality of her research. In 2010, she was honored with a Menção Honrosa (Honorable Mention) for her work on Mentha piperita L. in treating Schistosoma mansoni, earning 2nd place in diagnostics and treatment. She continued to gain academic acclaim with awards at major conferences, including the VI Congresso da Sociedade Paulista de Parasitologia (2012) and the XXII B-MRS Meeting in 2024, highlighting her work on cytotoxic responses and innovative parasitological control methods. In 2024, her project on the parasitological and pathological evaluation of AW-HRL-C for schistosomiasis control was notably recognized by UNIFESP.

🧠 Impact and Influence in Experimental Immunology

Joice’s dedication to experimental immunology and cytometry has allowed her to mentor and influence upcoming researchers, especially in specialized fields such as flow cytometry. Her recent specialization in Immunology and Oncohematology by Flow Cytometry (2021–2022) at IPESSP further enriched her profile, showcasing her commitment to continuous learning and application of advanced technologies in immune profiling. Her ability to merge classical immunopathology with state-of-the-art cytometric tools reflects her versatility and forward-thinking scientific approach.

🌱 Legacy and Future Contributions in Biomedical Science

Poised to make lasting contributions, Joice Margareth de Almeida Rodolpho stands at the forefront of research into host-pathogen interactions, parasitic disease management, and immune cell function modulation. Her unique interdisciplinary approach—integrating molecular biology, natural product pharmacology, and immunological techniques—positions her as a valuable contributor to both academic research and potential therapeutic advancements. She is expected to lead innovative research in the treatment of neglected tropical diseases and immunological disorders, with implications for global health.

🔬 Research Field Relevance and Scientific Identity

As a scholar deeply embedded in the Brazilian scientific ecosystem, Joice’s identity is reflected in her multiple citation forms, indicating her widespread academic collaborations and international visibility. Her expertise bridges evolutionary genetics, biotechnology, cytometry, and immunoparasitology—making her a multifaceted researcher. Her contributions are cited under various names such as “RODOLPHO, JOICE M. A.” and “Joice Margareth de Almeida Rodolpho,” reflecting a robust presence in scholarly literature and ensuring her work continues to guide parasitological and immunological research for years to come.

Publication

Title: Biomarkers and Mental Disorders: A Relevance Analysis Using a Random Forest Algorithm
Authors: Joice M. A. Rodolpho; Krissia F. Godoy; Bruna D. L. Fragelli; Jaqueline Bianchi; et al.
Year: 2025

Title: Death Risk Score Model of Hospitalized COVID‐19 Patients: A Cohort Study
Authors: Gustavo A. Cruz; Thais B. Boteon; Henrique Pott; Joice M. A. Rodolpho; et al.
Year: 2025

Title: Synergistic Antifungal Effect and In Vivo Toxicity of a Monoterpene Isoespintanol Obtained from Oxandra xylopioides Diels
Authors: Orfa I. C. Martínez; Alberto Angulo; Joice Rodolpho; Krissia F. Godoy; et al.
Year: 2024

Title: Synergistic Antifungal Effect and In Vivo Toxicity of the Monoterpene Isoespintanol Obtained from Oxandra xylopioides Diels (Preprint)
Authors: Orfa I. C. Martínez; Alberto Angulo; Joice M. A. Rodolpho; et al.
Year: 2024

Title: Carbon Black CB-EDA Nanoparticles in Macrophages: Changes in the Oxidative Stress Pathway and in Apoptosis Signaling
Authors: Joice M. A. Rodolpho; Krissia F. Godoy; Bruna D. L. Fragelli; et al.
Year: 2023

Title: HGPRT and PNP: Recombinant Enzymes from Schistosoma mansoni and Their Role in Immunotherapy during Experimental Murine Schistosomiasis
Authors: Bruna D. L. Fragelli; Ana C. Fattori; Joice M. A. Rodolpho; et al.
Year: 2023

Title: Titanium Dioxide Nanoparticle (TiO2 NP) Induces Toxic Effects on LA-9 Mouse Fibroblast Cell Line
Authors: Ana C. M. Fattori; Patricia Brassolatti; Joice M. A. Rodolpho; et al.
Year: 2023

Title: Analysis of Cytotoxicity and Genotoxicity in a Short-Term Dependent Manner Induced by a New Titanium Dioxide Nanoparticle in Murine Fibroblast Cells
Authors: Pedrino, M.; Brassolatti, P.; Joice M. A. Rodolpho; et al.
Year: 2022

Title: Functionalized Titanium Nanoparticles Induce Oxidative Stress and Cell Death in Human Skin Cells
Authors: Brassolatti, P.; Joice M. A. Rodolpho; Krissia F. Godoy; et al.
Year: 2022

Title: Toxicological Effects of the Mixed Iron Oxide Nanoparticle (Fe₃O₄ NP) on Murine Fibroblasts LA-9
Authors: Alves Feitosa, K.; Joice M. A. Rodolpho; et al.
Year: 2022

🧾 Conclusion

Joice Rodolpho’s academic journey and scientific contributions reveal a researcher of high caliber, committed to advancing our understanding of host-pathogen dynamics and immune system function. Her work, grounded in rigorous experimentation and innovation, holds promise for developing novel therapies for neglected tropical diseases. With a forward-looking approach and interdisciplinary expertise, she stands out as a key contributor in biomedical science, poised to influence future discoveries in immunopathology and disease control.

Ivan Zivotic | Molecular Neuroscience | Best Researcher Award

Posted on 14/06/2025 by Neuroscientists

Dr. Ivan Zivotic | Molecular Neuroscience | Best Researcher Award

Dr. Ivan Zivotic, Vinča Institute of Nuclear Sciences, University of Belgrade, Serbia.

Dr. Ivan Životić is a Serbian molecular geneticist whose research focuses on the genetic epidemiology of complex human diseases such as atherosclerosis, congenital kidney anomalies, and chronic inflammatory conditions. With a Ph.D. in Molecular Biology from the University of Belgrade and a master’s background in applied genetics, he has cultivated a strong academic and research foundation. Currently affiliated with the “Vinča” Institute of Nuclear Sciences, he has authored 16 scientific papers and coauthored over 40 abstracts, contributing meaningfully to the fields of genomics and transcriptomics. His expertise lies in deciphering gene-disease associations using modern molecular and computational tools.

Profile

Orcid

🎓 Early Academic Pursuits

Born on July 23, 1986, in Belgrade, Serbia, Dr. Ivan Životić embarked on a promising academic journey rooted in the life sciences. His passion for unraveling the genetic underpinnings of human diseases led him to the Faculty of Biology at the University of Belgrade. He obtained a Master’s degree in Molecular Biology and Physiology in 2011, specializing in applied genetics within the Department of Population Genetics. His master’s thesis explored the role of GST M1 and GST T1 gene deletion polymorphisms in multiple sclerosis, laying the groundwork for his deep engagement in genetic epidemiology. He continued with doctoral studies at the same faculty, where he focused on the molecular biology of eukaryotes. His Ph.D. thesis examined the association between genetic variants on chromosome 9p21 and transcription levels of CDKN2B and HACD4 genes with atherosclerosis and its complications, graduating with an impressive average grade of 9.7.

🧬 Research Focus in Molecular Genetics

Dr. Životić’s research is rooted in molecular genetics with a core focus on the genetic epidemiology of complex human diseases. His scientific curiosity revolves around how genomic and transcriptomic profiles contribute to the development of conditions such as atherosclerosis, congenital kidney anomalies, and chronic inflammatory diseases. His work integrates molecular tools and population studies to understand genetic variants and their influence on disease onset, making valuable contributions to the broader fields of genomics and transcriptomics. His dedication to uncovering genetic risk factors reflects a commitment to improving predictive medicine and tailored healthcare strategies.

🏥 Professional Endeavors in Medical Sciences

Professionally, Dr. Životić holds a distinguished position at the “Vinča” Institute of Nuclear Sciences, a leading Serbian national research institute affiliated with the University of Belgrade. His role within this multidisciplinary environment places him at the forefront of translational research, bridging the gap between laboratory discoveries and clinical applications. Collaborating with esteemed researchers and clinicians, he continually advances the understanding of how molecular mechanisms translate into disease phenotypes, particularly within the realm of cardiovascular and renal health.

📚 Contributions to Scientific Literature

Dr. Životić has authored 16 research papers in internationally recognized SCI journals and coauthored over 40 scientific abstracts presented at prestigious conferences. These publications represent his steady and thoughtful contributions to the academic community. His scholarly output reflects not only the depth of his investigations but also his role in team-based science. His Scopus-indexed h-index of 4 and 54 heterocitations (as of February 12, 2025) demonstrate a growing influence in the field of molecular medical research.

🏆 Accolades and Academic Recognition

Dr. Životić’s academic achievements are complemented by consistent scholarly excellence. With high average grades throughout his university education and a commendable Ph.D. thesis addressing significant clinical concerns, he has earned recognition within his academic circles. His scientific insights into cardiovascular genomics have positioned him as a promising voice among early-career researchers in Serbia’s biomedical community. His educational accomplishments, including supervision under renowned expert Dr. Maja Živković, reflect a foundation built on rigor and mentorship.

🌍 Scientific Impact and Global Relevance

The research conducted by Dr. Životić holds substantial relevance not only within Serbia but also internationally, given the global burden of atherosclerosis and other complex diseases. His work on gene expression, chromosomal variations, and their clinical correlations contributes to a better understanding of disease mechanisms that affect millions worldwide. His interdisciplinary approach, blending genetics, epidemiology, and bioinformatics, is increasingly critical for the development of precision medicine.

🔬 Legacy and Future Contributions

Looking forward, Dr. Životić is poised to make further breakthroughs in the fields of medical genomics and complex disease genetics. As the need for personalized medicine grows, his contributions are expected to inform diagnostic and therapeutic approaches that are tailored to individual genetic backgrounds. With a strong foundation, a collaborative research spirit, and an unwavering focus on human health, Dr. Životić is building a scientific legacy that will inspire future generations of geneticists and medical researchers.

Publication

Title: Expression of HMGB1, TGF-β1, BIRC3, ADAM17, CDKN1A, and FTO in Relation to Left Ventricular Remodeling in Patients Six Months after the First Myocardial Infarction: A Prospective Study
Authors: Jovana Kuveljic, Ana Djordjevic, Ivan Zivotic, Milica Dekleva, Ana Kolakovic, Maja Zivkovic, Aleksandra Stankovic, Tamara Djuric
Year: 2024

Title: Gene expression of chemokines CX3CL1 and CXCL16 and their receptors, CX3CR1 and CXCR6, in peripheral blood mononuclear cells of patients with relapsing-remitting multiple sclerosis – a pilot study
Authors: Ljiljana Stojkovic, Aleksandra Stankovic, Ivan Zivotic, Evica Dincic, Dragan Alavantic, Maja Zivkovic
Year: 2020

Title: The Effects of Aronia melanocarpa Juice Consumption on the mRNA Expression Profile in Peripheral Blood Mononuclear Cells in Subjects at Cardiovascular Risk
Authors: Ljiljana Stojković, Ivan Jovanovic, Manja Zec, Ivan Zivotic, Ivan Zivotić, Jovana Kuveljić, Ana Kolaković, Ivana Kolić, Ana Djordjević, Marija Glibetić et al.
Year: 2020

Title: CDKN2B gene expression is affected by 9p21.3 rs10757278 in CAD patients, six months after the MI
Authors: Zivotić I, Djurić T, Stanković A, Milasinovic D, Stankovic G, Dekleva M, Marković Nikolić N, Alavantić D, Zivković M
Year: 2019

Title: The HACD4 haplotype as a risk factor for atherosclerosis in males
Authors: Zivotić I, Djurić T, Stanković A, Ivančević I, Končar I, Milasinovic D, Stankovic G, Alavantić D, Zivković M
Year: 2018

Title: 9p21 locus rs10757278 is associated with advanced carotid atherosclerosis in a gender-specific manner
Authors: Zivotić I, Djurić T, Stanković A, Djordjević A, Končar I, Davidović L, Alavantić D, Zivković M
Year: 2016

Title: Genetic Variants in the Vicinity of LGALS-3 Gene and LGALS-3 mRNA Expression in Advanced Carotid Atherosclerosis: An Exploratory Study
Authors: Djordjevic A, Zivkovic M, Stankovic A, Zivotic I, Koncar I, Davidovic L, Alavantic D, Djuric T
Year: 2016

Title: The glutathione S-transferase T1 deletion is associated with susceptibility to multiple sclerosis
Authors: Živković M, Životić I, Dinčić E, Stojković L, Vojinović S, Stanković A
Year: 2013

✅ Conclusion

Dr. Životić exemplifies a new generation of biomedical scientists committed to bridging genetic science with clinical application. His work not only enhances the understanding of disease pathogenesis but also supports the advancement of personalized medicine. With a growing academic presence, a commitment to collaborative research, and a focus on translational impact, Dr. Životić is well-positioned to make lasting contributions to the global scientific community.

Rosario Osta | Molecular and Cellular Neuroscience | Best Researcher Award

Posted on 11/06/202511/06/2025 by Neuroscientists

Prof.Dr. Rosario Osta | Molecular and Cellular Neuroscience | Best Researcher Award

Prof. Dr. Rosario Osta, CIBERNED-Fundación Instituto de Investigación Sanitaria de Aragón-Universidad de Zaragoza, Spain.

Prof. Rosario Osta Pinzolas is a distinguished geneticist and full professor at the University of Zaragoza, Spain. Her academic roots in veterinary sciences and a Ph.D. in Genetics laid the foundation for a prolific career in biomedical research, particularly in the fields of neuroscience and genetic disorders. With leadership roles in multiple high-profile research consortia such as CIBERNED, TRICALS, and ENCALS, she has established herself as a central figure in neurodegenerative disease research. Her scholarly output includes over 100 indexed publications, multiple national and international research projects, and an h-index exceeding 45.

Profile

Orcid

Scopus

🎓 Early Academic Pursuits

Rosario Osta Pinzolas began her academic journey with a solid foundation in veterinary sciences, graduating as Licenciada en Veterinaria from the University of Zaragoza in 1989. Her academic inclinations quickly shifted toward molecular genetics, leading her to complete a Ph.D. in Genetics at the same university in 1994. Her early studies were driven by a deep curiosity about the mechanisms of heredity and gene expression, setting the tone for a lifelong commitment to biomedical research. These formative years cultivated her scientific rigor and sowed the seeds for a career that would eventually bridge basic science and translational medicine.

🧬 Professional Endeavors in Genetics and Biomedicine

Prof. Osta currently holds the esteemed title of Catedrática (Full Professor) in the Department of Anatomy, Embryology, and Genetics at the Faculty of Veterinary Medicine, University of Zaragoza. Since 2018, she has led her department with a focus on integrative biomedical sciences. She is the principal investigator of the LAGENBIO group recognized by both the Aragon Health Research Institute and the Government of Aragon. Under her leadership, the group has developed two major subprograms: TERAGEN and REGENERAGEN. As coordinator of the “Neuroscience and Mental Health Program” at IISA, she has spearheaded numerous efforts to understand and address neurological diseases through genetic approaches.

🧠 Contributions and Research Focus in Neuroscience

A prominent figure in neuroscience, Prof. Osta’s research lies at the intersection of genetics and neurodegeneration. She is currently the principal investigator of the only Aragon-based group within CIBERNED (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas), reflecting her national influence. Her team represents Zaragoza in prominent European consortia such as TRICALS and ENCALS, both focused on amyotrophic lateral sclerosis (ALS) and other motor neuron diseases. Through more than 100 indexed publications, predominantly in top-tier journals, her work delves into the molecular underpinnings of neurological disorders and explores regenerative medicine strategies, thereby contributing to innovative therapeutic avenues.

🧪 Accolades and Recognition in Scientific Excellence

Prof. Osta’s academic and research career has been punctuated by consistent recognition. She has completed five research productivity periods and one technology transfer period, acknowledged by CNEAI — a mark of sustained scientific impact. She has led over 74 research projects and contributed to more than 100 collaboration contracts, earning her four competitive research awards from respected institutions including CORIS, AREA, IIS, and SEBBM. Her contributions have been lauded not only for scientific quality but also for practical relevance in biomedical advancements.

🚀 Innovation and Impact in Translational Research

An ardent advocate for science with societal impact, Prof. Osta has significantly contributed to technology transfer. She holds nine patents, five of which have been licensed to industry partners. Her collaborations with companies have led to meaningful translational outputs, emphasizing her role in bridging the gap between academic research and real-world solutions. As former Director of the Technology Transfer and Innovation Secretariat at the University of Zaragoza for nearly a decade, she played a crucial role in institutional innovation strategies. Her involvement in joint university-company chairs and her role in the UZ Technology-Based Business Creation Committee for over 12 years further underscore her influence on academic entrepreneurship.

📚 Mentorship and Educational Leadership

Beyond the lab, Prof. Osta has left a profound mark as an educator and mentor. Since 2013, she has coordinated the Interuniversity Doctoral Program in Biomedical and Biotechnological Sciences, a joint initiative between the Universities of Zaragoza and La Rioja. Her mentorship includes the supervision of 13 Ph.D. theses — 9 of which earned international distinction and 6 received extraordinary doctoral awards. Her influence extends to guiding numerous undergraduate and master’s theses, fostering a new generation of scientists with a deep commitment to research excellence and innovation.

🌍 Legacy and Future Contributions

Prof. Rosario Osta’s legacy is defined by her ability to integrate scientific discovery, mentorship, and innovation. As a member of the Scientific Committee of the Luzón Foundation, her vision reaches beyond academia into public health advocacy and strategic research planning. With nearly 19,000 citations on Google Scholar and an h-index of 45, her work continues to inspire and inform global research communities. Her continued leadership in collaborative European projects ensures her contributions will shape the future of neuroscience, genetics, and translational medicine for years to come.

Publication

Title: Novel FKBP prolyl isomerase 1A (FKBP12) ligand promotes functional improvement in SOD1G93A amyotrophic lateral sclerosis (ALS) mice
Authors: L. Moreno-Martinez, N. Gaja-Capdevila, L. Mosqueira-Martín, R. Osta, F.J. Gil-Bea
Year: 2025

Title: Identifying Hub Genes and miRNAs Associated with Alzheimer’s Disease: A Bioinformatics Pathway to Novel Therapeutic Strategies
Authors: E. Gascón, A.C. Calvo, N. Molina, P. Zaragoza, R. Osta
Year: 2024

Title: Comparative Blood Profiling Based on ATR-FTIR Spectroscopy and Chemometrics for Differential Diagnosis of Patients with Amyotrophic Lateral Sclerosis—Pilot Study
Authors: K. Tkachenko, J.M. González Sáiz, A.C. Calvo, R. Osta, C. Pizarro Millán
Year: 2024

Title: Sex differences on constitutive long non-coding RNA expression: Modulatory effect of estradiol and testosterone in muscle cells
Authors: T. López-Royo, L. Moreno-Martinez, L. Moreno-García, R. Manzano, R. Osta
Year: 2024

Title: Differentially expressed lncRNAs in SOD1 G93A mice skeletal muscle: H19, Myhas and Neat1 as potential biomarkers in amyotrophic lateral sclerosis
Authors: T. López-Royo, L. Moreno-Martinez, P. Zaragoza, R. Manzano, R. Osta
Year: 2024

Title: Proteomic profiling of human plasma extracellular vesicles identifies PF4 and C1R as novel biomarker in sarcopenia
Authors: P. Aparicio, D. Navarrete-Villanueva, A. Gómez-Cabello, R. Osta, R. Manzano
Year: 2024

Title: Sporadic Amyotrophic Lateral Sclerosis Skeletal Muscle Transcriptome Analysis: A Comprehensive Examination of Differentially Expressed Genes
Authors: E. Gascón, P. Zaragoza, A.C. Calvo, R. Osta
Year: 2024

Title: Intermediate Repeat Expansion in the ATXN2 Gene as a Risk Factor in the ALS and FTD Spanish Population
Authors: D. Borrego-Hernández, J.F. Vázquez-Costa, R. Domínguez Rubio, M. Povedano, A. García-Redondo
Year: 2024

Title: New Insights into Endogenous Retrovirus-K Transcripts in Amyotrophic Lateral Sclerosis
Authors: L. Moreno-Martinez, S. Macías-Redondo, M.H.P. Strunk, R. Osta, J. Schoorlemmer
Year: 2024

Title: Analysis of Plasma-Derived Exosomal MicroRNAs as Potential Biomarkers for Canine Idiopathic Epilepsy
Authors: M. García-Gracia, L. Moreno-Martinez, A. Hernaiz, S. García-Belenguer, I. Martín-Burriel
Year: 2024

🏆 Conclusion

Based on her outstanding research contributions, innovation in translational science, mentorship record, and leadership within national and European research programs, Prof. Rosario Osta Pinzolas is an exceptionally strong candidate for the Best Researcher Award. Her profile reflects not only academic excellence but also societal impact and visionary leadership. While there is room for enhanced global outreach, her sustained achievements and contributions make her highly deserving of this prestigious recognition.

Katherine Mandeville | Clinical Neuroscience | Best Researcher Award

Posted on 26/05/2025 by Neuroscientists

Dr. Katherine Mandeville | Clinical Neuroscience | Best Researcher Award

Dr. Katherine Mandeville, University of California San Diego, United States.

Dr. Katherine Mandeville is a distinguished pediatric emergency physician and academician whose career reflects a commitment to excellence in both clinical care and research. With a strong academic foundation in biochemistry and medicine from the University of New Mexico, she pursued advanced clinical training at leading institutions such as the University of Colorado and Phoenix Children’s Hospital. Her academic and clinical trajectory has led her to a prominent role at the University of California, San Diego (UCSD), where she serves as an Associate Clinical Professor in the Department of Pediatrics, Division of Emergency Medicine at Rady Children’s Hospital.

Profile

Scopus
Orcid

🎓 Early Academic Pursuits

Dr. Katherine Mandeville’s journey into the medical field was rooted in a solid foundation in science and critical inquiry. She began her academic path studying biochemistry and chemical engineering at the University of New Mexico, where she also explored non-degree coursework at Albuquerque Technical Vocational Institute. Her early academic versatility revealed a strong analytical mindset and a deep interest in human health and systems. In 1999, she earned her Medical Degree from the University of New Mexico School of Medicine, setting the stage for a career centered on both patient care and research-driven excellence.

🩺 Professional Endeavors

Following her graduation from medical school, Dr. Mandeville pursued intensive clinical training at the University of Colorado Health Sciences Center, where she completed her pediatric internship, residency, and advanced to a fellowship in Pediatric Emergency Medicine at Phoenix Children’s Hospital. These formative experiences immersed her in the fast-paced, high-stakes environment of emergency pediatrics. Since joining the University of California, San Diego (UCSD), she has progressed from Associate to Assistant and now Associate Clinical Professor within the Department of Pediatrics, Division of Emergency Medicine at Rady Children’s Hospital. Her clinical role complements her academic responsibilities, fostering a dual commitment to exceptional care and education.

🔬 Contributions and Research Focus

Dr. Mandeville’s research trajectory is marked by a keen interest in bridging clinical care and evidence-based medicine. Her decision to pursue a Master of Science in Clinical Research at the University of New Mexico’s Health Sciences Center demonstrates a deliberate move toward translational science and healthcare innovation. Her work integrates real-world clinical challenges in pediatric emergency departments with scientific inquiry, focusing on improving outcomes for vulnerable pediatric populations. While her biography does not specify individual research projects or publications, her advanced training and consistent academic appointments suggest active involvement in research development, collaborative studies, or clinical protocols aimed at advancing pediatric emergency medicine.

🏆 Accolades and Recognition

Dr. Mandeville’s credentials reflect longstanding recognition in the field of pediatrics. She is certified by the American Board of Pediatrics in both General Pediatrics and Pediatric Emergency Medicine—a rare and prestigious combination. Her sustained licensure in California and prior credentials in Nevada highlight her clinical credibility, while her affiliation with institutions such as UCSD and Rady Children’s Hospital place her in nationally ranked centers of pediatric care. The progression of her academic titles further underscores institutional trust in her leadership, mentorship, and research capabilities.

🌍 Impact and Influence

Throughout her career, Dr. Mandeville has consistently served at the intersection of medicine, mentorship, and systemic impact. At Rady Children’s Hospital—a major referral center in Southern California—she has influenced both the quality of emergency pediatric care and the professional development of young physicians. Her expertise and clinical judgment are undoubtedly shaping the training experiences of future pediatricians, residents, and fellows. Moreover, her presence in a teaching hospital and research-driven university ensures that her influence extends beyond clinical settings into broader academic and public health circles.

🔗 Legacy and Future Contributions

Dr. Mandeville is well-positioned to leave a lasting legacy in pediatric emergency care and clinical education. With her strong academic background, research training, and high-level clinical experience, she represents the next generation of clinician-researchers dedicated to evidence-based improvements in pediatric health. Her ongoing work at UCSD is likely to contribute to innovations in emergency care delivery, interdisciplinary teaching, and policy development in children’s health services. As medical systems increasingly prioritize translational research and quality improvement, her dual role as educator and researcher will only grow more pivotal.

🧪 Commitment to Research-Driven Medicine

What sets Dr. Mandeville apart is her integration of research training into her clinical identity. The MSCR program she completed reflects a structured and methodical approach to data analysis, study design, and outcomes research—skills that are vital in transforming bedside observations into peer-reviewed evidence. While not all research is visible in public citations, her long-term affiliation with academic medical centers and role in an evidence-based specialty suggests a strong alignment with research objectives. Her career embodies the principle that the best medical care is informed by rigorous scientific investigation, continuous learning, and collaborative innovation.

Publication

Title: Effects of Timing to Diagnosis and Appendectomy in Pediatric Appendicitis
Author(s): Mandeville K, Monuteaux M, Pottker T, Bulloch B
Year: 2015

Title: The Frequency of Postreduction Interventions After Successful Enema Reduction of Intussusception
Author(s): Lessenich EM, Kimia AA, Mandeville K, Li J, Landschaft A, Tsai A, Bachur R
Year: 2015

Title: Intussusception: Clinical Presentations and Imaging Characteristics
Author(s): Mandeville K, Chien M, Willyerd FA, Mandell G, Hostetler MA, Bulloch B
Year: 2012

Title: Management of the Child After Enema-Reduced Intussusception: Hospital or Home?
Author(s): Chien M, Willyerd FA, Mandeville K, Hostetler MA, Bulloch B
Year: 2012

Title: Using Appendicitis Scores in the Pediatric ED
Author(s): Mandeville K, Pottker T, Bulloch B, Liu J
Year: 2010

Title: Brain Oxygen Utilization Is Unchanged by Hypoglycemia in Normal Humans: Lactate, Alanine, and Leucine Uptake Are Not Sufficient to Offset Energy Deficit
Author(s): Lubow JM, Piñón IG, Avogaro A, Cobelli C, Treeson DM, Mandeville KA, Toffolo G, Boyle PJ
Year: 2005

Title: Presentation, Evaluation, and Outcomes of Infants Under Three Months With Skull Fractures
Author(s): Mandeville K
Year: Not specified (date not provided in source)

🏁 Conclusion

Dr. Katherine Mandeville exemplifies the role of a clinician-researcher in modern medicine. Her robust educational background, commitment to pediatric emergency care, and pursuit of research-driven solutions have positioned her as a valuable leader in her field. Her influence spans clinical innovation, academic mentorship, and systemic healthcare improvements, making her a key contributor to both pediatric patient outcomes and medical education. As she continues her work at UCSD and Rady Children’s Hospital, her legacy is poised to grow through impactful research, mentorship, and advocacy for best practices in pediatric emergency medicine.

Daon Hwang | Clinical Neuroscience | Best Researcher Award

Posted on 13/05/2025 by Neuroscientists

Mr. Daon Hwang | Clinical Neuroscience | Best Researcher Award

Mr. Daon Hwang, Depatment of Physical Therapy, Korea Natiional University of Transportation, South Korea.

Daon Hwang is a dedicated physical therapist and Ph.D. candidate at Korea National University of Transportation, with a strong academic and clinical foundation in adult neurological rehabilitation. His research portfolio includes six completed projects and six peer-reviewed publications, focusing on stroke rehabilitation, gait analysis, neurorehabilitation, and assistive device development. With a practical background in clinical therapy and consulting experience in device usability, he effectively bridges the gap between research and real-world application. His active involvement in professional organizations further enriches his contributions to the rehabilitation field.

Profile

Orcid

🎓 Early Academic Pursuits

Daon Hwang began his academic journey with a deep interest in the human body and its recovery mechanisms, leading him to pursue a career in physical therapy. He earned both his Bachelor’s and Master’s degrees in Physical Therapy from Korea National University of Transportation (KNUT). His early academic years were marked by diligence and a curiosity-driven approach to the complexities of neurological rehabilitation. His strong academic performance and growing passion for evidence-based practice set the stage for his current doctoral research.

💼 Professional Endeavors

As a licensed physical therapist, Daon Hwang has accumulated meaningful clinical experience, particularly in the field of adult neurological rehabilitation. His hands-on work with stroke patients has fueled his commitment to integrating practical therapy with innovative research. His current role as a Ph.D. candidate at KNUT allows him to bridge clinical practice with academic exploration, where he also provides consultancy on assistive devices. Daon continues to evolve both as a practitioner and as a scholar in the rehabilitation sciences.

🧠 Contributions and Research Focus

Daon’s primary research focuses include stroke rehabilitation, neurorehabilitation, gait analysis, and the development of assistive technologies. He has successfully completed six research projects, exploring diverse aspects such as proprioceptive training and the usability of rehabilitation devices. His scholarly output includes six peer-reviewed journal publications—two in SCI-indexed journals and four in KCI-indexed journals. These works contribute to enhancing therapeutic protocols and improving patients’ functional outcomes, particularly in post-stroke recovery.

🧪 Research Innovation and Impact

Daon’s innovative contributions are evident in his work with assistive device usability, having collaborated on three industry consulting projects to improve device design and user experience for stroke patients. His research has not only advanced academic knowledge but also offered real-world applicability in clinical settings. His studies often highlight the integration of biomechanical analysis and rehabilitation techniques to create more personalized and effective interventions.

🏅 Accolades and Professional Involvement

While Daon Hwang has not yet published books or acquired patents, his membership in several esteemed professional bodies reflects his dedication to continued learning and contribution to the field. He is an active member of the Korean Academy of Orthopedic Manipulative Physical Therapy, the Korean Physical Therapy Association, and the Korea Proprioceptive Neuromuscular Facilitation Association. Through these affiliations, he stays at the forefront of developments in physical therapy and rehabilitation science.

🌍 Influence and Collaboration

Though he has not formally reported collaborative research projects, Daon’s consulting work and clinical partnerships demonstrate a growing sphere of influence. His findings are increasingly referenced by peers and practitioners, particularly in the areas of gait mechanics and neuro-motor rehabilitation. His dual role in academia and practice ensures his research remains grounded in clinical relevance.

🔮 Legacy and Future Contributions

Looking ahead, Daon Hwang aspires to further integrate technology with neurorehabilitation strategies, aiming to develop more efficient, adaptive tools for stroke survivors. His doctoral work and future post-doctoral goals center on refining rehabilitative methods through data-driven research and interdisciplinary collaboration. With a vision of contributing meaningfully to global rehabilitation science, Daon is poised to leave a lasting legacy of innovation, empathy, and excellence in physical therapy.

Publication

Title: Usability Test for an Over-Ground Walking Assistance Robotic Device Based on the Mecanum Wheel
Authors: Daon Hwang; EunPyeong Choi; Ki Hun Cho
Year: 2025

Title: Changes in Balance Ability, Physical Performance and Lower Extremity Proprioception according to the Compression Stockings in University Students
Authors: Daon Hwang; Hyeong Gyu Kim; Na Young Kang; Eun Seo Park; Hyun Young Yoo; Jun Young Lee; Seo Yeong Jang; Cheol Woo Hwang; Ki Hun Cho
Year: 2025

Title: Usability Test for a Cane-Combined Weight Support Feedback Device
Authors: Daon Hwang; Ki Hun Cho
Year: 2024

Title: Usability Test for Motion Tracking Gait Assistive Walker
Authors: Daon Hwang; Ki Hun Cho
Year: 2023

Title: The Effect of Mirror Therapy on the Balance, Gait and Motor Function in Patients with Subacute Stroke: A Pilot Study
Authors: Min-Su Song; Soon-Hee Kang
Year: 2021

Title: Effect of Mirror Therapy on the Balance, Gait and Motor Function in Patients with Subacute Stroke
Authors: Min-Su Song; Soon-Hee Kang
Year: 2021

✅ Conclusion

Driven by a passion for enhancing recovery outcomes in stroke patients, Daon Hwang has positioned himself as a promising scholar and practitioner in the field of physical therapy. His blend of academic rigor, clinical expertise, and innovation in assistive technologies reflects a career marked by meaningful impact and ongoing growth. As he advances toward completing his Ph.D., his work continues to shape the future of neurorehabilitation—promoting evidence-based practices and contributing to patient-centered healthcare innovations.

Che Ping Cheng | Translational Neuroscience | Best Researcher Award

Posted on 02/05/2025 by Neuroscientists

Prof. Che Ping Cheng | Translational Neuroscience | Best Researcher Award

Prof. Che Ping Cheng, Wake Forest University School of Medicine, United States.

Dr. Che Ping Cheng, M.D., Ph.D., FAHA, is a distinguished cardiovascular physiologist and internal medicine specialist whose career has been dedicated to advancing the understanding of heart function and failure. From earning his medical degree in China to completing a Ph.D. in Physiology at Wayne State University, and later conducting pivotal postdoctoral research at Wake Forest School of Medicine, Dr. Cheng has consistently pursued excellence in science and education. His research on ventricular mechanics, volume loading, and heart failure has significantly influenced both experimental cardiology and clinical practice. Recognized as a Fellow of the American Heart Association, he is also a dedicated mentor, shaping the next generation of cardiovascular researchers through his academic leadership.

Profile

Scopus

🎓 Early Academic Pursuits

Dr. Che Ping Cheng’s journey into medicine and science began in Nanjing, China, where he earned his M.D. degree from Nanjing Railway Medical University in 1977. His early academic path reflected a deep interest in understanding the intricacies of human health, particularly in cardiovascular physiology. Driven by a desire to expand his knowledge and research capabilities, Dr. Cheng pursued his Ph.D. in Physiology at Wayne State University School of Medicine in Detroit, Michigan, completing his degree in 1986. Under the mentorship of Dr. Robert S. Shepard, his doctoral work focused on exploring the mechanisms of cardiovascular response to volume loading in a canine model with tricuspid valvulectomy, setting a strong foundation for his lifelong focus on heart function and disease mechanisms.

🩺 Professional Endeavors

Following his academic training, Dr. Cheng embarked on postdoctoral studies at the Bowman Gray School of Medicine (now part of Wake Forest School of Medicine), where he continued to cultivate his expertise in internal medicine and cardiovascular physiology. Between 1986 and 1988, he served as a Postdoctoral Fellow under the guidance of Dr. William C. Little. His research during this period focused on ventricular dynamics and the physiological factors affecting active ventricular filling, which would later inform his broader work on heart failure and cardiac function. Dr. Cheng has since remained at Wake Forest School of Medicine, where he is currently a distinguished member of the Section on Cardiovascular Medicine.

🧪 Contributions and Research Focus

Dr. Cheng’s career has been characterized by a deep commitment to advancing the understanding of cardiac hemodynamics, ventricular interaction, and heart failure mechanisms. His research has explored how ventricular function responds under altered physiological states, and how these responses inform disease progression and treatment strategies. His early animal model studies have provided critical insights into the interplay between structural and functional changes in the heart, especially in the context of diastolic dysfunction and volume overload conditions. Dr. Cheng has also made significant strides in translating these findings to clinical contexts, influencing how cardiologists approach diagnosis and therapy.

🏅 Accolades and Recognition

Throughout his career, Dr. Cheng has received considerable recognition for his scholarly contributions. He is a Fellow of the American Heart Association (FAHA), an honor that reflects his standing in the field of cardiovascular research and his commitment to scientific excellence. His work has earned the respect of colleagues and institutions alike, leading to numerous invitations to contribute to collaborative projects, serve on peer-review panels, and mentor future generations of cardiovascular researchers.

🌍 Impact and Influence

Dr. Cheng’s work has had a lasting impact on both experimental and clinical cardiology. By elucidating the mechanistic basis of ventricular dysfunction, he has helped shift paradigms in heart failure management, particularly in the areas of ventricular interdependence and preload responsiveness. His research findings are frequently cited in textbooks and high-impact journals, and they continue to inform guidelines for cardiac care and interventions. Through his work at Wake Forest and beyond, Dr. Cheng has played a pivotal role in bridging laboratory discoveries with bedside applications.

👨‍🏫 Legacy and Mentorship

As a respected mentor and educator, Dr. Cheng has dedicated a significant portion of his career to training medical students, residents, and postdoctoral fellows. His mentorship has influenced numerous emerging scholars in cardiovascular medicine, many of whom have gone on to successful academic and clinical careers. His guidance combines a rigorous scientific approach with a deep sense of responsibility to patient care and scientific integrity, shaping a legacy that extends well beyond his own research output.

🔬 Future Contributions and Vision

Looking ahead, Dr. Cheng remains committed to the advancement of cardiovascular research, with a continued focus on uncovering the cellular and mechanical determinants of heart disease. His vision includes fostering collaborative projects that integrate biomedical engineering, imaging, and computational modeling to further understand cardiac performance. With decades of experience and a forward-thinking approach, Dr. Cheng’s future contributions are poised to leave a lasting mark on the field of translational cardiovascular medicine.

Publication

Title: Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension
Authors: Sun, Xiaoqiang; Cao, Jing; Chen, Zhe; Ferrario, Carlos M.; Cheng, Cheping
Year: 2023
Journal: Heliyon

Title: Calmodulin-dependent protein kinase II activation promotes kidney mesangial expansion in streptozotocin-induced diabetic mice
Authors: Mikhailov, Alexei V.; Liu, Yixi; Cheng, Hengjie; Lin, Jen Jar; Cheng, Cheping
Year: 2022
Journal: Heliyon

Title: Chronic GPR30 agonist therapy causes restoration of normal cardiac functional performance in a male mouse model of progressive heart failure: Insights into cellular mechanisms
Authors: Zhang, Xiaowei; Li, Tiankai; Cheng, Hengjie; Groban, Leanne; Cheng, Cheping
Year: 2021
Journal: Life Sciences

Title: Chronic Ca2+/calmodulin-dependent protein Kinase II inhibition rescues advanced heart failure
Authors: Liu, Yixi; Shao, Qun; Cheng, Hengjie; Zhao, David Xiao Ming; Cheng, Cheping
Year: 2021
Journal: Journal of Pharmacology and Experimental Therapeutics

Title: The Angiotensin-(1–12)/Chymase axis as an alternate component of the tissue renin angiotensin system
Authors: Ferrario, Carlos M.; Groban, Leanne; Wang, Hao; Sun, Xuming; Ahmad, Sarfaraz
Year: 2021
Journal: Molecular and Cellular Endocrinology

Title: Reversal of angiotensin-(1–12)-caused positive modulation on left ventricular contractile performance in heart failure: Assessment by pressure-volume analysis
Authors: Li, Tiankai; Zhang, Zhi; Zhang, Xiaowei; Ferrario, Carlos M.; Cheng, Cheping
Year: 2020
Journal: International Journal of Cardiology

Title: Female Heart Health: Is GPER the Missing Link?
Authors: Groban, Leanne; Tran, Q. K.; Ferrario, Carlos M.; Wang, Hao; Lindsey, Sarah H.
Year: (Not specified, but likely 2020 or 2021)
Journal: (Not specified)

🏁 Conclusion

Dr. Cheng’s legacy is one of intellectual rigor, clinical relevance, and mentorship. His work has not only deepened the scientific understanding of cardiac physiology but has also shaped modern approaches to diagnosing and managing heart failure. With a career spanning continents and disciplines, Dr. Cheng continues to be a guiding force in cardiovascular medicine, and his future contributions are anticipated to further advance the frontiers of heart research and patient care.

Lijuan Song | Cellular Neuroscience | Best Researcher Award

Posted on 26/04/2025 by Neuroscientists

Prof. Lijuan Song | Cellular Neuroscience | Best Researcher Award

Prof. Lijuan Song, Shanxi University of Chinese Medicine, China.

Throughout my career, I have passionately committed myself to integrating traditional Chinese medicine and Western medicine to advance the prevention and treatment of brain diseases, particularly ischemic cerebrovascular diseases and neurodegenerative disorders. By leading 14 national and provincial-level research projects, publishing over 130 academic papers, and contributing significantly to educational reform, I have built a strong foundation of scientific innovation and clinical excellence. With achievements recognized both nationally and internationally, and a consistent focus on combining research, teaching, and clinical work, I have significantly impacted the fields of neuroprotection and integrative medicine.

Profile

Scopus

🎓 Early Academic Pursuits

From the outset of my academic journey, I committed myself to the profound study of both traditional Chinese medicine and Western medicine, aspiring to bridge these two disciplines for the betterment of brain disease treatment. I pursued a rigorous path of education and research, laying a strong foundation that later allowed me to integrate diverse medical perspectives. Early in my career, I developed a particular interest in ischemic cerebrovascular diseases and neurodegenerative conditions, setting the stage for my lifelong mission to innovate in these critical areas.

🩺 Professional Endeavors

My professional career has been a dynamic blend of teaching, clinical practice, and scientific research, with a special focus on the prevention and treatment of brain diseases. I have successfully presided over 14 prestigious national and provincial-level projects, including those funded by the National Natural Science Foundation of China and the China Postdoctoral Science Foundation. Through my work, I have consistently emphasized the value of integrating traditional Chinese medicine with modern Western practices, ensuring that my clinical and research contributions are both culturally rooted and globally relevant.

🔬 Contributions and Research Focus

Throughout my research journey, I have concentrated on ischemic cerebrovascular diseases and neurodegenerative diseases, pioneering integrated approaches for their prevention and treatment. I have published 133 scientific papers, including 45 in SCI-indexed journals, with nearly 700 citations and an H-index of 15. One of my papers published in Neural Regeneration Research (NRR) has been recognized in the ESI highest citation list, achieving an impressive 97 citations. Beyond scientific research, I have also contributed significantly to educational innovation, authoring educational reform articles in the China Journal of Traditional Chinese Medicine and editing influential academic books.

🏆 Accolades and Recognition

My dedication to scientific advancement and education has earned me multiple prestigious honors. As the first author, I received the First Prize of the Academic Achievement Award from the China Association for the Promotion of Traditional Chinese Medicine Research. I have secured three authorized patents and two software copyrights, further showcasing my commitment to innovation. Additionally, my work has been featured through oral presentations at internationally renowned academic forums such as the Autoimmunity Congress and the World Stroke Congress, and recognized by respected platforms like Logic Neuroscience and Neuroweekly.

🌍 Impact and Influence

My influence extends beyond academia into public science education and medical philosophy dialogues. I have been repeatedly invited to deliver popular science talks and academic lectures at events like the Medical Philosophy Expert Meeting Room. My presentation at the 2022 International Neural Regeneration Summit Forum earned the Most Popular Award, affirming my ability to translate complex research into impactful and accessible knowledge for diverse audiences.

📚 Legacy in Education and Publishing

In addition to research and clinical achievements, I have made significant contributions to academic publishing and educational reform. My independently authored book, Progress in Integrated Traditional Chinese and Western Medicine Prevention and Treatment of Ischemic Cerebrovascular Disease, was published by People’s Health Publishing House. I have served as the first editor-in-chief for three important books, including Exploration of Teaching Models in Higher Education Pharmaceutical Education, which was honored by its selection into the “Library of Young Scholars in Universities,” marking a lasting contribution to the future of pharmaceutical education.

🚀 Future Contributions and Aspirations

Looking ahead, I aspire to further deepen the integration of traditional Chinese and Western medicine, particularly in brain disease prevention and therapy. I am committed to leading new research directions, fostering international collaborations, and nurturing a new generation of scholars who value the richness of cross-cultural medical practices. My future endeavors will continue to reflect a relentless pursuit of scientific excellence, compassionate clinical practice, and transformative education for the global health community.

Publication

Title: Effect of tetramethylpyrazine on neuroinflammation after cerebral ischemia and hypoxia based on mannose-binding lectin
Authors: Y. Duan, Yanzhe; J. Hua, Jianlin; Y. Yan, Yuqing; L. Song, Lijuan
Year: 2025

Title: Polysaccharides from Ganoderma lucidum attenuate cognitive impairment in 5xFAD mice by inhibiting oxidative stress and modulating mitochondrial dynamics via the Nrf2/antioxidative axis activation
Authors: J. Yu, Jiezhong; C. Ma, Cungen
Year: 2025

Title: Hydroxysafflower yellow A alleviates the inflammatory response in astrocytes following cerebral ischemia by inhibiting the LCN2/STAT3 feedback loop
Authors: L. Song, Lijuan; Y. Wu, Yige; L. Yin, Lijun; B. Xiao, Baoguo; C. Ma, Cungen
Year: 2025

Title: Mechanism of senegenin in improving lipopolysacchride-induced inflammatory response of BV2 microglial cell
Authors: B. Mu, Bingtao; M. Guo, Minfang; J. Yu, Jingwen; J. Yu, Jiezhong; L. Song, Lijuan
Year: 2025

Title: Effectiveness and Safety of Blending Traditional Chinese Medicine With Western Medicine for Enhanced Secondary Stroke Prevention: A Meta-analysis of RCTs
Authors: C. Wen, Chunli; L. Song, Lijuan; C. Ma, Cungen; F. Hu, Fengyun; L. Zhu, Linggqun
Year: 2025

🎯 Conclusion

Driven by a deep belief in the power of integration between ancient wisdom and modern science, I have continuously sought to pioneer new frontiers in brain disease treatment. My work has not only advanced research but also nurtured future generations through educational contributions and public science communication. Moving forward, I remain committed to expanding the reach and depth of integrated medicine, aiming to create a lasting legacy of innovation, healing, and academic excellence for global healthcare advancement.

Wenhui He | Cellular Neuroscience | Innovative Research Award

Posted on 21/04/2025 by Neuroscientists

Mr. Wenhui He | Cellular Neuroscience | Innovative Research Award

Mr. Wenhui He, Army Medical University, China.

Wenhui He is a dedicated lecturer and researcher at the Army Medical University, where she has spent eight years teaching biochemistry and molecular biology. With a strong academic background and deep expertise in neural regulation and cardiovascular diseases, her research delves into complex mechanisms underlying aortic dissection and atherosclerosis. Through her dual roles in education and scientific discovery, she contributes significantly to both student development and the broader medical research community. Her work not only adds to the scientific understanding of cardiovascular pathophysiology but also informs potential therapeutic strategies.

Profile

Scopus

🎓 Early Academic Pursuits

Wenhui He embarked on her academic journey with a deep passion for unraveling the complexities of human biology, particularly focusing on the intricate workings of the cardiovascular system. Her early education laid a strong foundation in biochemistry and molecular biology, disciplines that would later become central to her teaching and research. With a commitment to excellence, she pursued advanced studies that equipped her with the scientific rigor and analytical skills necessary for impactful research in biomedical sciences.

🧪 Professional Endeavors

Currently serving as a lecturer at the School of Basic Medical Sciences, Army Medical University, Wenhui He has spent the past eight years educating future medical professionals. She specializes in biochemistry and molecular biology, delivering foundational knowledge with clarity and depth. Her role extends beyond teaching, as she actively contributes to the academic and research community within the university, balancing the dual responsibilities of pedagogy and scientific exploration.

🧬 Contributions and Research Focus

Wenhui He’s research is centered on the neural regulation and molecular mechanisms of cardiovascular diseases, particularly aortic dissection and atherosclerosis. Her work investigates the underlying signaling pathways and neurovascular interactions that drive the onset and progression of these conditions. By integrating neurobiology with vascular pathology, her studies aim to uncover therapeutic targets and improve understanding of disease mechanisms, thus contributing to the development of more effective interventions.

🏅 Accolades and Recognition

Throughout her academic and professional career, Wenhui He has earned the respect of her peers and students alike. While her contributions have been largely rooted in teaching and research, her dedication to academic excellence and her commitment to medical education have not gone unnoticed. Her role as a faculty member at a leading military medical institution speaks to her capabilities and the trust placed in her by the academic community.

🌍 Impact and Influence

Through her dual engagement in teaching and research, Wenhui He has had a meaningful impact on both the scientific community and the future of medicine. Her research contributes valuable knowledge to the fields of cardiovascular science and neurovascular biology, while her teaching helps shape the minds of tomorrow’s medical practitioners. The blend of theoretical insight and practical relevance in her work makes her an influential figure in her domain.

🔬 Legacy and Future Contributions

With a strong foundation in molecular biology and a clear focus on cardiovascular disease mechanisms, Wenhui He is poised to continue contributing groundbreaking research. Her future endeavors aim to bridge the gap between basic medical science and clinical application, ensuring that her work remains both scientifically significant and socially relevant. As she mentors young scientists and expands her research horizons, her legacy is likely to grow in scope and impact.

❤️‍🩹 Commitment to Cardiovascular Health

Wenhui He’s unwavering dedication to understanding and combating cardiovascular diseases reflects her commitment to public health. Her focus on conditions like aortic dissection and atherosclerosis not only addresses some of the leading causes of mortality but also aligns with global efforts to reduce the burden of chronic illnesses. Through education, research, and collaboration, she continues to make strides in protecting and improving heart health.

Publicatio

Title: From inflammation to remodelling: A novel BASP1⁺ monocyte subset as a catalyst for acute aortic dissection
Authors: Wenhui He, Sanjiu Yu, Jun Li, Wei Cheng, Shuangshuang Dai, et al.
Year: 2025

🏁 Conclusion

Combining passion, precision, and purpose, Wenhui He exemplifies the modern medical scientist—committed to excellence in teaching and innovation in research. Her journey reflects a meaningful integration of neuroscience, molecular biology, and cardiovascular science. As she continues to push boundaries in her field, her impact will be felt not only through her discoveries but also through the many students and researchers she inspires. Her career stands as a testament to the power of scientific curiosity and educational dedication in shaping a healthier future.